Ethyl Ester Precursor for Methanol-Free Radioactive Amino Acid Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing processes for producing [18F]FACBC often result in residual methanol, which is a regulated solvent according to ICH guidelines, necessitating a method to prevent its presence in the final product.
Innovation Solution
The process involves adding radioactive fluorine to a precursor compound syn-1-(N-(t-butoxycarbonyl)amino)-3-[(trifluoromethyl)sulfonyl]oxy]-cyclobutane-1-carboxylic acid ethyl ester and subsequently deprotecting it to form anti-[18F]-1-amino-3-fluorocyclobutanecarboxylic acid, using an ethyl ester instead of a methyl ester to prevent methanol retention.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If a methyl ester is used in the precursor compound for producing [18F]FACBC, then the synthesis process is simpler and more efficient, but residual methanol remains in the final product which violates regulatory standards
Solution Approach 1:
The patent changes the ester group parameter from methyl ester to ethyl ester in the precursor compound structure. This parameter change allows the use of ethanol as solvent instead of methanol, eliminating residual methanol from the final product while maintaining synthesis efficiency. The ethyl ester group undergoes the same radiochemical transformation to produce [18F]FACBC, but the solvent residue issue is resolved.
2Object-affected harmful factors
If an ethyl ester is used in the precursor compound, then residual methanol is prevented in the final product, but the synthesis process becomes more complex
Solution Approach 1:
The patent performs preliminary action by pre-installing the ethyl ester group in the precursor compound structure before the radiofluorination step. This preliminary structural preparation ensures that ethanol (not methanol) is used as the solvent throughout the synthesis process, thereby preventing residual methanol from the outset. The ethyl ester group is already in place in syn-1-(N-(t-butoxycarbonyl)amino)-3-[(trifluoromethyl)sulfonyl]oxy]-cyclobutane-1-carboxylic acid ethyl ester, eliminating the need for post-synthesis solvent exchange or additional purification steps to remove methanol.
3Productivity
If methanol is used as solvent in the synthesis of [18F]FACBC, then the reaction proceeds efficiently, but the final product fails to meet ICH guidelines for residual solvents
Solution Approach 1:
The patent applies inversion by switching from methanol-based synthesis to ethanol-based synthesis. Instead of trying to remove methanol residue after efficient synthesis, the approach is inverted: ethanol is used as the solvent from the beginning, and the precursor compound is designed with an ethyl ester group that is compatible with ethanol solvent. This inversion maintains reaction efficiency while ensuring regulatory compliance with ICH guidelines, as ethanol is either not restricted or has higher acceptable limits compared to methanol.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively prevents methanol from remaining in the synthesized [18F]FACBC, meeting regulatory standards for residual solvents.
Implementation Method 1
a radioactive halogen-labeled organic compound is obtained by allowing a radioactive halogen and a precursor compound to react
Implementation Method 2
subsequently deprotecting it to form anti-[18F]-1-amino-3-fluorocyclobutanecarboxylic acid
Data Source
Figure 1~3
AI summary
It is intended to provide a novel amino acid organic compound which can be used as a labeling precursor compound for radioactive halogen-labeled amino acid compounds including [18F]FACBC, and which prevents methanol from remaining in the radioactive halogen-labeled amino acid compounds produced therefrom. The novel amino acid organic compound is a compound represented by the following formula: wherein n is an integer of 0 or of 1 to 4; R1 is an ethyl, 1-propyl or isopropyl substituent; X is a halogen substituent or a group represented by -OR2; R2 is a straight-chain or branched-chain haloalkylsulfonic acid substituent with one to 10 carbon atoms, trialkylstannyl substituent with 3 to 12 carbon atoms, fluorosulfonic acid substituent or aromatic sulfonic acid substituent; and R3 is a protective group.